For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View

Sponsor Spike Success.

Agenus Secures Up to $340 Million Financing, Shares Surge 13%

Jul 13, 2026
Agenus Secures Up to $340 Million Financing, Shares Surge 13%

Agenus Inc. (NASDAQ:AGEN) experienced a 13% increase in its shares during premarket trading on Monday following the announcement of an $85 million private placement. This is intended to enhance the company's balance sheet and facilitate the ongoing development of its clinical pipeline. The deal also includes purchase warrants that could generate an additional $255 million if fully exercised, raising the total potential value of the financing package to $340 million.

The private placement was led by Commodore Capital, with participation from both existing and new institutional , including RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals. Agenus indicated that the proceeds from this financing will primarily be allocated to its Phase 3 ROBBIN clinical trial.

For Your Trading Desk
Trading Journals
Click For Trade View
Desk Accessories
Click For Trade View

Sponsor Spike Success.

If all warrants are exercised, Agenus anticipates that the financing will provide sufficient cash to sustain operations through the end of 2031. In conjunction with this financing announcement, the company revealed its decision to discontinue financial support for the BATTMAN Phase 3 study, which evaluates a treatment for late-line metastatic microsatellite stable (MSS) colorectal cancer. This strategic shift reflects Agenus's intention to prioritize resources towards programs that present stronger long-term development opportunities.

The new financing arrangement offers Agenus increased flexibility as it progresses its late-stage clinical portfolio while extending its projected cash runway. Investors reacted positively to the news, resulting in a notable rise in the stock price during premarket trading after the funding package was confirmed.

For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View
Trading Journals

Log entries, exits, and the reason you clicked. 'It looked promising' deserves a second look.

Click For Trade View

Sponsor Spike Success.

Recommended for You
Anthropic's IPO Opens to Australian Investors with Key Considerations
Breaking Market News Nov 16, 2026

Anthropic's IPO Opens to Australian Investors with Key Considerations

Anthropic, the company behind the Claude AI models, is set to debut on the NASDAQ, allowing Australian investors to apply for shares…

For Your Trading Desk
Trading Books

Price action, trading discipline, and the homework behind decisions made in seconds.

Click For Trade View
Trading Journals

Log entries, exits, and the reason you clicked. 'It looked promising' deserves a second look.

Click For Trade View
Desk Accessories

Monitor stands and desk organizers for a trading setup with fewer loose ends.

Click For Trade View
Market Microstructure & Order Flow

Books on liquidity, order books, spreads, and trade execution. A closer look at what happens between clicking and getting filled.

Click For Trade View
Algorithmic Trading & Python

Coding and research books for systematic traders. Backtests deserve scrutiny, not a victory lap.

Click For Trade View
Financial Statements & Earnings Research

References for reading earnings reports, cash flow, and balance sheets. The headline rarely brings all the footnotes.

Click For Trade View

Sponsor Spike Success.

Across our publications

In Other News

Latest stories from other publications.

Explore all publications (opens in a new tab)